Shutdown Fallout: NIH Rushes Health Grant Reviews Now
Published Date: 2/11/2026
Notice
Summary
The NIH’s Center for Scientific Review is holding two important closed meetings in February 2026 to review grant applications for big health research projects. These meetings were delayed by a 43-day government shutdown, so they’re happening quickly now to keep research funding on track. Scientists applying for grants and the public waiting on new health studies are affected by this urgent schedule.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Two NIH Grant Review Meetings Scheduled
The NIH Center for Scientific Review will hold two closed virtual meetings to review grant applications on February 20, 2026 (10:00 a.m. to 12:30 p.m.) and February 23, 2026 (1:00 p.m. to 2:00 p.m.). These meetings were rescheduled after a 43-day government shutdown and will evaluate applications for PAR-23-077 (RM1) and PAR-22-180 (MIRA).
Urgent Reviews to Avoid Funding Delays
Because the meetings were canceled during a 43-day shutdown, NIH says these urgent reviews must occur so evaluations can be submitted to national advisory councils for timely funding recommendations and statutory disbursement of NIH funds. The urgency is to keep funding decisions for biomedical research on schedule.
Meetings Closed to the Public
Both NIH review meetings will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) because discussions could disclose trade secrets, patentable material, or personal information. The public cannot attend these virtual meetings, which are being held to evaluate grant applications.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2026-02667, State of Michigan Radiological Emergency Preparedness Plan
FEMA has officially approved Michigan’s updated emergency plan to keep people safe near the Palisades Nuclear Plant. This plan affects residents and local governments in Allegan, Berrien, and Van Buren counties, ensuring they’re ready if a radiological emergency happens. The plan was approved in September 2025, with no new costs for the public, just stronger safety measures.
Next: 2026-02669, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in March 2026 to review and decide on important grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for health and science projects. If you’re involved in these grants, mark your calendar—these reviews shape future research funding but don’t involve new money changes or public access.